Press "Enter" to skip to content

New patent expiration for Astellas drug MYCAMINE

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Astellas drug MYCAMINE

Annual Drug Patent Expirations for MYCAMINE
Annual Drug Patent Expirations for MYCAMINE

Mycamine is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has seventy-six patent family members in thirty-two countries.

The generic ingredient in MYCAMINE is micafungin sodium. One supplier is listed for this compound. Additional details are available on the micafungin sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Astellas drug MYCAMINE
    Do NOT follow this link or you will be banned from the site!